Robert Bersin
Robert M Bersin

Robert M Bersin

Robert M Bersin
Specialty

Cardiology, Interventional Cardiology

Clinical Interests / Special Procedures Performed

Acute Coronary Syndromes, Amputations, Aneurysmal Arterial Disease, Aneurysms, Angioplasty, Aortic Aneurysm, Aortic Stent Grafts, Aortic Surgery (Laparoscopic), Aortic Valve Replacement, Arrhythmia Management, Arterial Bypass Grafting, Arterial Disease, Arterial Insufficiency, Arteriovenous Bypass, Arteriovenous Malformations, Atherosclerosis, Atrial Fibrillation, Cardiac Arrhythmias, Cardiac Campaign, Cardiac Catheterization, Cardiac CT, Cardiac Rehabilitation, Cardiac Risk Evaluation, Cardiac Risk Management, Cardiac Testing, Cardiac Transplantation, Cardiology, Cardiovascular Non-Invasive Imaging, Carotid Artery Disease, Carotid End Arterectomy, Carotid Endarterectomy, Carotid Stenting, Carotid Surgery, Cerebrovascular Diseases, Cholesterol, Cholesterol Management, Clinical Cardiology, Clinical Research & Educ., Clinical Trials, Coagulation Disorders, Coronary & Valvular Surgery, Coronary Angiography, Coronary Angioplasty, Coronary Artery Disease, Coronary Bypass, Coronary Disease Intervention, Coronary Stenting, Defibrillator Implantation, Dyslipidemia, Echocardiography (ECHO), EECP (Enhanced External Counter Pulsation), Electrocardiography (EKG), Endoscopic Vascular Surgery, Endovascular Aneurysm Therapy, Endovascular Surgery, Evidence-Based Health Care, Exercise Stress Testing, Heart Disease, Heart Failure, Heart Valve Repair, High Cholesterol, High-Risk Cardiac Surgery, Holter Monitoring, Hypercholesterolemia, Hyperlipidemia, Implantable Cardiac Defib, Interventional Cardiology, Interventional Radiology, Intracoronary Stent Placement, Invasive Diagnostics, Kidney Stents, Laser Therapy, Leg Vein Sclerosis, Limb Numbness, Limb Pain, Limb Salvage, Minimally Invasive Procedures, Mitral Valve Reconstruction, Mitral Valve Replacement, Myocardial Infarction, Nuclear Cardiology, Percutaneous Coronary Angiopl., Peripheral Vascular Disease, Peripheral Vascular Dx, PFO/ASD Closure, PTCA, Pulmonary Embolism, Radiofrequency Ablation, Renal Artery Bypass, Risk Factor Management, Rotational Athererectomy, Stent Graft For Aneurysm, Stenting, Stress Testing, Stroke Thrombolysis, Swedish Heart & Vascular Institute, Symptomatic Peripheral Vascular Disease, Thoracic Aorta Replacement, Thoracic Outlet Syndrome, Thrombosis - Recurrent, Thrombotic Disorders, Treadmill, Valvular Heart Disease, Varicose Veins, Vascular Access, Vascular Disease, Vascular Disease Medical Rx, Vascular Surgery, Vein Stripping, Venous Disease

  • Accepting Children: No
  • Accepting New Patients: Yes
  • Accepting Medicare: Yes
  • Accepting Medicaid/DSHS: Yes
Payment Methods Accepted:

Medicare, Medicaid/DSHS, Bill Insurance, VISA, Master Card, Cash, Check, Payment Plan, American Express, Discover Card

Insurance Accepted:

Contact this office for accepted insurance plans.

Additional Information:

Bachelor's degrees in psychology and biology: Stanford University; Medical Director of Endovascular Services, Seattle Cardiology and Swedish Medical Center; Director of Clinical Research,Cardiovascular Consultants of WA; Director of Endovascular Research, Hope Heart Institute; Fellow, American College of Physicians; Fellow, American College of Cardiology; Fellow, European Society of Cardiology; Fellow and Board of Trustees Member, Society for Cardiovascular Angiography and Interventions

Philosophy of Care

Complete cardiovascular care with an emphasis on detection, medical prevention, and minimally invasive management of cardiovascular and peripheral arterial diseases.

Medical School

University of California, Los Angeles

Residency

University of California, San Francisco

Fellowship(s)

University of California, San Francisco

Board Certifications

Internal Medicine, Cardiovascular Diseases, Interventional Cardiology

Additional Information:

Bachelor's degrees in psychology and biology: Stanford University; Medical Director of Endovascular Services, Seattle Cardiology and Swedish Medical Center; Director of Clinical Research,Cardiovascular Consultants of WA; Director of Endovascular Research, Hope Heart Institute; Fellow, American College of Physicians; Fellow, American College of Cardiology; Fellow, European Society of Cardiology; Fellow and Board of Trustees Member, Society for Cardiovascular Angiography and Interventions

RESEARCH, PUBLICATIONS & PRESENTATIONS
----------------------------------------------------------------------

NATIONAL PRINCIPAL INVESTIGATOR

2008 – 2010 US Principal Investigator, Cook REFORM Renal Stent IDE Trial, Swedish Medical Center, Seattle, Washington
2002 – 2004 US Principal Investigator, Teramed QUANTUM LP Endograft Study, Carolinas
1998 – 2000 National Co-Principal Investigator, AMIGO Atherectomy Trial, Carolinas Medical Center, Charlotte, North Carolina

PRINCIPAL INVESTIGATOR

2009 – Abbott CHOICE Carotid Stent Post-Market Surveillance Study, Swedish Medical Center, Seattle, Washington
2009 – CardioMems PRICELESS AAA Endograft Pressure Sensor Monitoring Study, Swedish Medical Center, Seattle, Washington
2008 – 2008 ARMOUR Carotid Embolic Protection IDE Trial, Swedish Medical Center, Seattle, Washington
2008 – 2009 VIVA SALVAGE Trial, Swedish Medical Center, Seattle, Washington
2008 – 2009 VIVA EXCEL Trial, Swedish Medical Center, Seattle, Washington
2007 – SAPPHIRE WW Carotid Stent Post-Market Surveillance Study, Swedish Medical Center, Seattle, Washington
2007 – 2008 Abbott CHOICE Carotid Stent Post-Market Surveillance Study, Overlake Hospital, Bellevue, Washington
2007 – 2008 SONOMA Carotid Stent Post-Market Surveillance Study, Swedish Medical Center, Seattle, Washington
2006 – 2007 Abbott XACT Carotid Stent Post-Market Surveillance Study, Overlake Hospital, Bellevue, Washington
2004 – 2004 VALOR Talent Thoracic Endograft Trial, Carolinas Medical Center, Charlotte, North Carolina
2004 – 2004 CAPTURE I Carotid Stent Post-Market Surveillance Study, Carolinas Medical Center, Charlotte, North Carolina
2004 – 2004 CASES Carotid Stent Post-Market Surveillance Study, Carolinas Medical Center, Charlotte, North Carolina
2002 – 2004 EndoTex CABERNET Carotid Stent Trial, Carolinas Medical Center, Charlotte, North Carolina
2002 – 2004 TALENT Enhanced Endograft Protocol, Carolinas Medical Center, Charlotte, North Carolina
2001 – 2004 Intertherapeutics Iliac Stent Trial, Carolinas Medical Center, Charlotte, North Carolina
2001 – 2004 Jo Stent SVG BARRICADE Trial, Carolinas Medical Center, Charlotte, North Carolina
2001 – 2002 Antrin Injection and Far Light, Carolinas Medical Center, Charlotte, North Carolina
2001 – 2002 Entire TIMI 23, Carolinas Medical Center, Charlotte, North Carolina
1999 – 2001 TALENT LPS Endograft Study, Carolinas Medical Center, Charlotte, North Carolina
1999 – 2000 WALLGRAFT Aneurysm/Trauma Study, Carolinas Medical Center, Charlotte, North Carolina
1998 – 2004 TALENT Emergency Use Endograft Protocol, Carolinas Medical Center, Charlotte, North Carolina
1998 – 2004 TALENT Low Risk Endograft Protocol, Carolinas Medical Center, Charlotte, North Carolina
1997 – 2004 AneuRx III Study, Carolinas Medical Center, Charlotte, North Carolina
1996 – 2004 AneuRx II Study, Carolinas Medical Center, Charlotte, North Carolina
1996 – 1998 NIRVANA NIR Stent Trial, Carolinas Medical Center, Charlotte, North Carolina
1995 – 1996 STRATAS Rotablator Trial, Carolinas Medical Center, Carolinas Medical Center, Charlotte, North Carolina
1993 – 1995 Optimal Atherectomy Restenosis Study OARS, Carolinas Medical Center, Charlotte, North Carolina
1992 – 1993 Genentech Intracoronary rt-PA Trial, Carolinas Heart Institute, Charlotte, North Carolina
1992 Erythropoietin in Congestive Heart Failure Pilot Study, Carolinas Heart Institute, Charlotte, North Carolina
1991 – 1993 CHAMPS Trial, Charlotte Heart Attack Medic-Prehospital Study, Carolinas Heart Institute, Charlotte, North Carolina Institute, Charlotte, North Carolina

CO-PRINCIPAL INVESTIGATOR

2010 – ev3 DEFINITIVE LE Trial, Swedish Medical Center, Seattle, Washington
2010 – ev3 DURABILITY SFA Stent Trial, Swedish Medical Center, Seattle, Washington
2009 – CABANA Carotid Stent Post-Market Surveillance Study, Swedish Medical Center, Seattle, Washington
2009 – BSC ORION Iliac IDE Trial, Swedish Medical Center, Seattle, Washington
2009 – 2009 BSC PLATINUM DES IDE Trial, Swedish Medical Center, Seattle, Washington
2005 – 2008 CREST Trial, Swedish Medical Center, Seattle, Washington
2003 – 2004 CREST Carotid Stent Trial, Carolinas Medical Center, Charlotte, North Carolina
2002 – 2004 COMBAT Trial, Carolinas Medical Center, Charlotte, North Carolina
2002 – 2004 CROSS Registry, Carolinas Medical Center, Charlotte, North Carolina
2002 – 2004 ENLIGHTEN-II Protocol, Carolinas Medical Center, Charlotte, North Carolina
2002 – 2003 TAXUS IV Protocol, Carolinas Medical Center, Charlotte, North Carolina
2002 – 2004 FilterWire BLAZE Registry, Carolinas Medical Center
2001 – 2002 REPLACE-2 Trial, Carolinas Medical Center, Charlotte, North Carolina
2001 – 2002 FilterWire FIRE Trial, Carolinas Medical Center, Charlotte, North Carolina
2001 – 2002 SWING Trial, Carolinas Medical Center, Charlotte, North Carolina
2001 – 2002 Gamma V Trial, Carolinas Medical Center, Charlotte, North Carolina
2001 – 2003 GUARD Trial, Carolinas Medical Center, Charlotte, North Carolina
2001 – 2002 SIRIUS Trial, Carolinas Medical Center, Charlotte, North Carolina
2001 – 2002 VICTORY Trial, Carolinas Medical Center, Charlotte, North Carolina
1996 – 1998 WIN/WINS Wallstent Trials, Carolinas Medical Center, Charlotte, North Carolina
1995 – 1996 PRESTO Trial, Carolinas Medical Center, Charlotte, North Carolina
1995 – 1996 Stent Anticoagulation Regimen Study STARS Trial, Carolinas Medical Center, Charlotte, North Carolina
1991 – 1992 Coronary Angioplasty Versus Excisional AtherectomyTrial CAVEAT, Carolinas Heart Institute, Charlotte, North Carolina
1991 – 1992 Lovastatin Restenosis Trial LRT, Carolinas Heart Institute, Charlotte, North Carolina
1990 – 1991 PATENT Trail, rt-PA and SCU-PA multicenter pro-urokinase patency trial, Carolinas Heart Institute, Charlotte, North Carolina
1990 – 1991 ACS Streak, alpha-14 and RX Perfusion catheter clinical trials, Carolinas Heart Institute, Charlotte, North Carolina
1989 – 1990 Thrombolysis and Angioplasty in Myocardial Infarction TAMI RESCUE Angioplasty Trial, Carolinas Heart Institute, Charlotte, North Carolina
1989 – 1990 Abbott Urokinase/rt-PA randomized trial, Carolinas Heart Institute, Charlotte, North Carolina
1989 – 1990 UCSI autoperfusion catheter (APC) and Probe 3 clinical trials, Carolinas Heart Institute, Charlotte, North Carolina
1987 – 1989 DCA Lactic Acidosis Multicenter International Trial, and Principal Investigator at the Intensive Care Unit, Moffitt Hospital, University of California, San Francisco

ORIGINAL PUBLICATIONS

A Prospective, Single-Arm, Multicenter Clinical Study of the Safety and Effectiveness of the Formula Balloon-Expandable Stent for Treatment of Renal Artery Stenosis. Bersin RM, Ansel GM, Rizzo, A, Smouse, HB, Sinha, S, Sachar, R, Dave, R, Weinstock, BS, Feldman, R, Roubin, GS. Catheter Cardiovasc Interv 2012; in press.

A Meta-analysis of Proximal Occlusion Device Outcomes in Carotid Artery Stenting. Bersin, RM Stabile, E, Ansel GM, Clair, DG, Hopkins LN, Nikas D, Reimers B, Sievert H, and Rubino R. Catheter Cardiovasc Interv 2012; in press.

The Evolution of Low-Profile Endograft Design. Bersin RM Endovascular Today 2011; 3: 54-58.

Now Begins the Era of Combination Therapy for Acute Ischemic Stroke. Bersin RM Rev Bras Cardiol Invasiva 2010; 18(3): 249-250.

Safety and effectiveness of the INVATEC MO.MA® proximal cerebral protection device during carotid artery stenting: Results from the ARMOUR pivotal trial. Ansel GA, Hopkins LN, Jaff MR, Rubino P, Bacharach MJ, Scheinert D, Myla S, Das T, Cremonesi A. Cathet Cardiovasc Interv 2010; 76 (1): 1–8.

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine (developed in collaboration with the American College of Emergency Physicians). Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM. J Am Coll Cardiol 2010;55:e27–129.

Does carotid stent design influence outcomes? Bersin RM Catheter Cardiovasc Interv 2008; 72: 863-866.

Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ: 1-year results in the CABERNET trial. LN Hopkins, S Myla, E Grube, JC Wehman, EI Levy, RM Bersin, JD Joye, DJ Allocco, L Kelley, and DS Baim. Catheter Cardiovasc Interv 2008; 71: 950-60.

A Different Approach: Employing a Bidirectional Technique for Treating an Iliac CTO. Bersin RM. Endovascular Today 2006; 5(9): 72-74.

Clinical competence statement on thoracic endovascular aortic repair (TEVAR)--multispecialty consensus recommendations: a report of the SVS/SIR/SCAI/SVMB writing committee to develop a clinical competence standard for TEVAR. Society of Vascular Surgery/Society of Intervention Radiology/Society of Cardiovascular Angiography and Interventions/Society of Vascular Medicine and Biology Writing Committee to Develop a Clinical Competence Standard for TEVAR, KJ Hodgson, JS Matsumura, E Ascher, MD Dake, D Sacks, K Krol, and RM Bersin.  J Vasc Interv Radiol 2006; 17: 617-21.

Clinical competence statement on thoracic endovascular aortic repair (TEVAR)—multispecialty consensus recommendations: A Report of the SVS/SIR/SCAI/SVMB Writing Committee to Develop a Clinical Competence Standard for TEVAR. Hodgson KJ, Matsamura JS, Ascher E, Dake MD, Sacks D, Krol K and Bersin R. J Vasc Surg 2006; 43: 858-62.

Prevention of Contrast- Induced Nephrophy with Sodium Bicarbonate. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Moore AV, Simonton CA, Rittase RA, Norton HJ, Kennedy TP. JAMA 2004; 291(19): 2328-2334.

Comparison of Directional Coronary Atherectomy and Stenting versus Stenting Alone for the Treatment of De-Novo and Restenotic Coronary Artery Narrowing. Stankovic G, Colombo A, Bersin R, Popma J, Sharma SK, Cannon LA, Gordon P, Nutka D, Braden G, and Collins M: Am J Cardiol 2004; 93: 953-958.

Long Segment Disease. Bersin RM. Endovascular Today 2003; Nov/Dec: 38-40.

The Duett Pro Sealing Device: A Novel Approach to Vascular Sealing. Bersin RM. Endovascular Today 2003; April: 65-66.

Rotational And Directional Coronary Atherectomy. Bersin RM and Simonton CA. Catheter Cardiovasc Interv 2003; 58(4): 485-499.

For the STRATAS Investigators, Results of the Study To determine Rotablator And Transluminal Angioplasty Strategy (STRATAS). Whitlow PL, Bass TA, Kipperman RM, Sharaf BL, Ho KKL, Cutlip DE, Zhang Y, Kuntz RE, Williams DO, Lasorda DM, Moses JW, Cowley MJ, Eccleston DS, Horrigan MBBX, Bersin RM, Ramee SR, Feldman T The American Journal of Cardiology, 2001; 87(6): 699-705.

Long-Term Clinical Follow-up of Patients Treated with the Coronary Rotablator: A Single–Center Experience. Bersin RM, Cedarholm JC, Kowalchuk GJ and Fitzgerald PJ. Catheter Cardiovasc Interv 1999; 46(4): 399-405.

Remodeling after Directional Coronary Atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): A Serial Angiographic and intravascular Ultrasound Analysis from the Optimal Atherectomy Restenosis Study. Lansky AJ, Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Baim DS, Kuntz , Simonton CA, Bersin RM, Hinohara T, Fitzgerald PJ and Leon MB. J Am Coll Cardiol 1998; 32(2): 329-337.

’Optimal’ Directional Coronary Atherectomy: Final Results of the Optimal Atherectomy Restetnosis Study (OARS). Simonton CA, Leon MB, Baim DS, Hinohara T, Kent KM, Bersin RM, Wilson BH, Mintz GS, Fitzgerald PJ, Yock PG, Popma JJ, Ho KKL, Cutlip DE, Senerchia C, Kuntz Circulation 1998; 97(4): 332-339.

Dichloroacetate as Metabolic Therapy for Myocardial Ischemia and Failure. Bersin RM and Stacpoole PW. Am Heart J 1997; 134(5): 841-855.

Surgical management of instrumentation-induced coronary artery dissection. Robicsek FR, Bersin RM, Kowalchuk G, Kollar A. J Card Surg 1995; 10:626-631.

Lack of effect of lovastatin on restenosis after coronary angioplasty. Weintraub WS, Boccuzzi SJ, Klein JL and the Lovastatin Restenosis Trial Study Group. N Eng J Med 1994; 331:1331-1337.

Natural history and course of acquired lactic acidosis in adults. DCA-Lactic Acidosis Study Group. Stacpoole PW, Wright EC, Baumgartner TG, Bersin RM, Buchalter S, Curry SH, Duncan CA, Harman EM, Henderson GN, Jenkinson S. Lachin JM, Lorenz A, Schneider SH, Siegel JH, Summer WR, Thompson D, Wolfe CL, Zorovich B. Am J Med 1994; 97:47-54.

Improved hemodynamic performance and mechanical efficiency in congestive heart failure with sodium dichloroacetate. Bersin RM, Wolfe C, Kwasman M, Lau D, Klinski C, Tanaka K, Khorrami P, DeMarco T, Chatterjee K. J Amer Coll Cardiol 1994; 23(7): 1617-1624

Mobile cardiac catheterization: Comparison with outpatient and inpatient catheterization at tertiary facilities. Elliott CM, Bersin RM, Fedor JM, Gallagher JJ, Jordan L, Simonton CA, Svenson RH, Wilson BH, Zimmern SH. Cath Cardiovasc Diagn 1994; 31:8-15.

Mobile cardiac catheterization registry: Report of the first one thousand and one patients. Bersin RM, Elliott CM, Elliott AV, Fedor JM, Gallagher JJ, Jordan L, Simonton CA, Svenson RH, Wilson BH, Zimmern SH. Cath Cardiovasc Diagn 1994; 31:1-7.

Importance of oxygen-hemoglobin binding to oxygen transport in congestive heart failure. Bersin RM, Kwasman M, Lau D, Klinski C, Tanaka K, Khorrami P, DeMarco T, Wolfe C, Chatterjee K. Br Heart J 1993; 70:443-447.

Balloon rupture during peripheral stent implantation: A new technique for balloon retrieval. Bersin RM, Gold RS. Cath Cardiovasc Diagn 1993; 29:292-295.

A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. Stacpoole PW, Wright EC, Baumgartner TG, Bersin RM, Buchalter S, Curry SH, Duncan CA, Harman EM, Henderson GN, Jenkinson S, Lachin JM, Lorenz A, Schneider SH, Siegel JH, Summer WR, Thompson D, Wolfe CL, Zorovich B. N Engl J Med 1992; 327:1564-1569.

Metabolic and hemodynamic effects of sodium bicarbonate administration in patients with heart disease. Bersin RM, Chatterjee K, Arieff AI. Amer J Med 1989; 86:7-14.

Primary lactic alkalosis. Bersin RM, Arieff AI. Amer J Med 1988; 85:867-871.

Improved hemodynamic function during hypoxia with carbicarb, a new buffering agent for the management of acidosis. Bersin RM, Arieff AI. Circulation 1988; 77:227-233.

Recent advances in the therapy of lactic acidosis. Bersin RM, Arieff AI. Intensive Care World 1987; 4:128-133.

BOOK CHAPTERS

1. Husby G, Williams, Jr. RC, Bersin RM, Lewis MK. “Antineuronal Antibodies in Diseases Affecting the Basal Ganglia, Particularly Sydenham’s and Huntington’s Chorea, In: “Clinical Neuroimmunology, “ ed. F.C. Rose (Oxford: Blackwell Scientific Publications, 1978), p. 90-105.

2. Bersin RM. Management of Acute Myocardial Infarction. In: “Cardiac Surgery: State of the Art Reviews, Vol. 3(2), “ eds. IL Kron, C Mavroudis. (Philadelphia: Hanley and Belfus, 1990), p. 445-483.

3. Bersin RM. Prevention of Acute Myocardial Infarction in the Reperfusion Era: Focus on Antiplatelet Therapy. In: “Annual Review of Pulmonary and Critical Care Medicine, “ eds. Matthay RA, Matthay MA, Wiedemann HP. (Philadelphia: Hanley and Belfus, 1990), p. 251-254.

4. Bersin RM. Management of Acute Myocardial Infarction in the Reperfusion Era. In: “Annual Review of Pulmonary and Critical Care Medicine,” eds. Matthay RA, Matthay MA, Wiedemann HP. (Philadelphia: Hanley and Belfus, 1990), p 255-282.

5. Bersin RM. Effects of sodium bicarbonate on myocardial metabolism and circulatory function during hypoxia. In: “Hypoxia, Metabolic Acidosis and the Circulation,” ed., AI Arieff. (New York: Oxford University Press, 1992), p. 139-174.

6. Bersin RM. Complications of Peripheral Procedures. In: “King S: The Interventional Cardiologist,” (Part VI, Ch. 60), 2006

ABSTRACTS

1. Bersin, RM Stabile, E, Ansel GM, Clair, DG, Hopkins LN, Nikas D, Reimers B, Sievert H, and Rubino R. A Meta-analysis of Proximal Occlusion Device Outcomes in Carotid Artery Stenting. Eurointervention 2012; 8 (Suppl N): 217.

2. Bersin RM, Blankenship TH, Chris TB, Frederick CL, Dasher BV, Reid B. Long-term Angiographic Patency of Palmaz-Stents in the Renal Arteries. J Endovasc Surg 2000; 7(1): I-3.

3. Sharaf BL, McKendall GR, Love TW, Bersin RM, Talley D, Williams DO for the Intracoronary t-PA Investigators. Treatment of intracoronary thrombus: Successful lysis with intracoronary t-PA. Abstr., 45th Annual Scientific Sessions, American College of Cardiology, March, 1996. J Am Coll Cardiol 1996; 27(2) (Suppl 1): 332A.

4. Baim DE, Simonton CA, Popma JJ, Hinohara T, Bersin RM, DeFeo T, Kent KM, Yock PG, Kuntz RE for the OARS investigators. Mechanism of luminal enlargement by optimal atherectomy – IVUS insights from the OARS study. Abstr., 45th Annual Scientific Sessions, American College of Cardiology, March, 1996. J Am Coll Cardiol 1996; 27(2) (Suppl 1): 291A.

5. Mintz GS, Fitzgerald PJ, Kuntz RE, Simonton, CA, Bersin RM, Yock PG, Popma JJ, Baim DE for the Oars Investigators. Lesion site and reference vessel remodeling after directional coronary atherectomy: An analysis from the Optimal Atherectomy Restenosis Study. Abstr., 68th Scientific Sessions, American Heart Association, November, 1995. Circulation 1995; 92(8): 1-93.

6. Simonton CA, Leon MB, Kuntz RE, Popma JJ, Hinohara T, Mintz GS, Bersin RM, Yock PG, Wilson BH, Cutlip DE, Baim DE. Acute and late clinical and angiographic results of directional atherectomy in the Optimal Atherectomy Restenosis Study. Abstr., 68th Scientific Sessions, American Heart Association, November, 1995. Circulation 1995; 92(8): I-545.

7. Leon MB,Kuntz RE, Popma JJ, Simonton CA, Hinohara T, Mintz GS, Bersin RM, Yock PG and Baim DS. Acute Angiographic, Intravascular Ultrasound and Clinical Results of Directional Atherectomy in the Optimal Atherectomy Restenosis Study. Abstr., 44th Annual Scientific Sessions, American College of Cardiology, March, 1995. J Am Coll Cardiol 1995; 25(2)(Supplement 1): 137A.

8. Fitzgerald PJ, Mooney MR, Susuki S, Ohtaki E, Walter PD, Dorros G, Bersin RM, Russo RJ, Wyrens FJ, Yock PG. Lesion composition impacts size and symmetry of stent expansion: Initial report from the STRUT registry. Abstr., 44th Annual Scientific Sessions, American College of Cardiology, March, 1995

9. Mintz GS, Kuntz RE, Popma JJ, Simonton CA, Hinohara T, Bersin RM, Painter JA, Yock PG, Griffin J, Kleiber B, Leon MB. Residual plaque burden in patients undergoing ultrasound-guided “optimal” directional atherectomy. Abstr., 67th Scientific Sessions, American Heart Association, November, 1994.

10. Popma JJ, Mintz GS, Kuntz RE, Simonton CA, Vetter J, Bersin RM, Satler LF. Impact of adjunctive balloon angioplasty following ultrasound-guided “optimal” directional atherectomy. Abstr., 67th Scientific Sessions, American Heart Association, Nov, 1994.

11. Simonton CA, Kuntz RE, Ho KKL, Vetter J, Fitzgerald PJ, Bersin RM, Lewis LT, Conway T, Popma JJ. Intravascular ultrasound and quantitative angiographic correlates of reference vessel diameter after “optimal” directional coronary atherectomy: Clinical implications for balloon selection. Abstr., 67th Scientific Sessions, American Heart Association, November, 1994.

12. Bersin RM, Davis NH, Applegate DS, Williams TC, Goldberg MA, Enny C, Dempsey WH, Matthews E. Facilitation of oxygen-hemoglobin dissociation in patients with congestive heart failure with recombinant human erythropoietin (r-HuEPO): A pilot study. Abstr., 1st Annual Meeting of the European Hematology Association, June, 1994. Br J Haematol 1994; 87 (Suppl 1): 153.

13. Bersin RM, Davis NH, Applegate DS, Williams TC, Goldberg MA, Enny C, Dempsey WH, Matthews E. Direct facilitation of oxygen-hemoglobin dissociation with erythropoietin: Report of a pilot study in congestive heart failure patients. Abstr., 35th Annual Meeting of the American Society of Hematology, December, 1993. (Blood, in press).

14. Bersin RM, Davis NH, Applegate DS, Williams TC, Goldberg MA, Enny C, Dempsey WH, Matthews E. A New Therapeutic Strategy for the Treatment of Congestive Heart Failure: Facilitation of Oxygen Unloading with Erythropoietin: Preliminary Report of a Pilot Study. Abstr., XVth Congress of the European Society of Cardiology, September, 1993. Eur Heart J 1993; 14(Suppl): 380.

15. Bersin RM, Williams TC. Improved metabolic and hemodynamic function with a new buffering agent for cardiac arrest. Abstr., 42nd Annual Scientific Sessions, American College of Cardiology, March, 1993. J Am Coll Cardiol 1993; 21(2): 254A.

16. Bersin RM, Elliott CM, Elliott AV, Fedor JM, Gallagher JJ, Jordan L, Simonton CA, Svenson RH, Wilson BH, Zimmern SH. Mobile cardiac catheterization registry: Report of the first one thousand patients. Abstr., Annual Scientific Sessions, Society for Cardiac Angiography and Interventions, May, 1992. Cath Cardiovasc Diag 1992; 26: 73.

17. Elliott CM, Bersin RM, Fedor JM, Gallagher JJ, Jordan L, Simonton CA, Svenson RH, Wilson BH, Zimmern SH. Mobile cardiac catheterization: Comparison with outpatient and inpatient catheterization at tertiary facilities. Abstr., 41st Annual Scientific Sessions, American College of Cardiology, April, 1992. J Am Coll Cardiol 1992; 19: 42A.

18. Elliott CM, Bersin RM, Fedor JM, Gallagher JJ, Jordan L, Simonton CA, Svenson RH, Wilson BH, Zimmern SH. Mobile cardiac catheterization: Preliminary report of an ongoing registry. Abstr., 63rd Scientific Sessions, American Heart Association, November, 1990. Circulation 1990; 82: 90.

19. Bersin RM, Kwasman M, Demarco T, Lau D, Klinski C. Golonka J, Wolfe C, Chatterjee K. Quantitative importance of oxygen-hemoglobin binding to oxygen transport in congestive heart failure. Abstr., 39th Annual Scientific Sessions, American College of Cardiology, March, 1990. J Am Coll Cardiol 1990; 15: 208A.

20. Bersin RM, Kwasman M, DeMarco T, Lau D, Klinski C, Wolfe C, Chatterjee K. Improved hemodynamic function in chronic heart failure with the metabolic agent sodium dichloroacetate. Abstr., 39th Annual Scientific Sessions, American College of Cardiology, March, 1990. J Am Coll Cardiol 1990; 15: 157A.

21. Graf H, Mayer G, Cada E, Muller MM, Bersin RM. Is erythropoietin a direct stimulator of 2,3 DPG? Abstr., Annual Meeting, American Society for Clinical Investigation, April, 1988. Clin Res 1988; 36: 482A.

22. Bersin, RM, Chatterjee K. Impaired coronary vasodilator responsiveness in patients with dilated cardiomyopathy. Abstr., 60th Scientific Sessions, American Heart Association, November, 1987. Circulation 1987; 76: IV-459.

23. Bersin, RM, Chatterjee K, Arieff AI. Metabolic and hemodynamic effects of sodium bicarbonate in patients with heart disease. Abstr., Xth International Congress of Nephrology, July, 1987. Trans Intl Soc Nephrol 1987; 10: 106.

24. Bersin RM, Arieff AI. Metabolic and cardiac effects of carbicard versus sodium bicarbonate in dogs with hypoxic lactic acidosis. Abstr., Xth International Congress of Nephrology, July, 1987. Trans Intl Soc Nephrol 1987; 10: 106.

25. Bersin RM, Arieff AI. Metobolic effects of carbicarb versus bicarbonate in dogs with hypoxic lactic acidosis. Abstr., Annual Meeting, American Society for Clinical Investigation, May, 1987. Clin Res 35: 634A.

26. Bersin RM, Arieff AI, Chatterjee K. Importance of 2,3-diphosphoglyceric acid to oxygen transport in congestive heart failure. Abstr., 36th Annual Scientific Sessions, American College of Cardiology, March, 1987. J Am Coll Cardiol 1987; 9: 186A.

27. Bersin RM, Arieff AI. Primary lactic alkalosis: A new syndrome. Abstr., 19th Annual Meeting, American Society of Nephrology, December, 1986. Kidney Int 1986; 31:191, 1987.

28. Bersin RM, Horton A, Arieff AI. Hemodynamic Effects of Carbicarb versus NaHCO3 in Dogs with Hypoxic Lactic Acidosis. Abstr., 59th Scientific Sessions, American Heart Association, November, 1986. Circulation 1986; 74: II-240.

29. Bersin RM, Chatterjee K, Arieff AI. Cardiovascular effects of bicarbonate in patients with hypoxia and cardiac decompensation. Abstr., 35th Annual Scientific Sessions, American College of Cardiology, March, 1986. J Am Coll Cardiol 1986; 7(2):76A.

30. Bersin RM, Chatterjee K, Arieff AI. Metabolic and systemic effects of bicarbonate in hypoxic patients with heart failure. Abstr., 18th Annual Scientific Sessions, American Society of Nephrology, December, 1985. Kidney Int 1986; 29:180.

31. Bersin RM, Tubau J. Merz R, Wolf A and Schiller N. Diagnostic yield of echocardiography with routine treadmill testing. Abstr., 58th Scientific Sessions, American Heart Association, November, 1985. Circulation 1985; 72: III-449.

Offices

Swedish Heart & Vascular
550 17th Ave.
Suite 680
Seattle, WA 98122
Phone: 206-215-4545
Fax: 206-215-4550
Monday-Friday, 8 a.m.-5 p.m.

Map & Directions

Swedish Heart & Vascular - Aberdeen
1104 Basich Blvd.
Aberdeen, WA 98020
Phone: 360-532-2633
Fax: 360-532-2593

Map & Directions

Physicians: Is this your profile? Click here for info